¼¼°èÀÇ È£¸£¸ó ´ëü¿ä¹ý(HRT) ½ÃÀå
Hormone Replacement Therapy (HRT)
»óǰÄÚµå : 1514246
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 276 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,464,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,393,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ È£¸£¸ó ´ëü¿ä¹ý(HRT) ½ÃÀåÀº 2030³â±îÁö 446¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»ó

2023³â¿¡ 293¾ï ´Þ·¯·Î Æò°¡µÈ ¼¼°èÀÇ È£¸£¸ó ´ëü¿ä¹ý(HRT) ½ÃÀåÀº ºÐ¼® ±â°£ 2023³âºÎÅÍ 2030³â±îÁö CAGR 6.2%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 2030³â¿¡´Â 446¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¿¡½ºÆ®·Î°Õ È£¸£¸ó ´ëü¿ä¹ýÀº CAGR 6.3%·Î ¼ºÀåÀ» Áö¼ÓÇϰí, ºÐ¼® ±â°£ Á¾·á ½Ã 242¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Àΰ£ ¼ºÀå È£¸£¸ó ´ëü¿ä¹ý ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 7.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 78¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 5.8%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ È£¸£¸ó ´ëü¿ä¹ý(HRT) ½ÃÀåÀº 2023³â 78¾ï ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 70¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ 2023³âºÎÅÍ 2030³â±îÁö CAGRÀº 5.8%·Î Àü¸ÁµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 5.6%¿Í 5.1%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

È£¸£¸ó ´ëü¿ä¹ý(HRT)-ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ

È£¸£¸ó ´ëü¿ä¹ý(HRT)Àº È£¸£¸ó ±ÕÇüÀÇ È¥¶õ°ú °áÇ̰ú °ü·ÃµÈ Áõ»ó, ƯÈ÷ ¿©¼ºÀÇ °»³â±â Àå¾Ö¿Í °ü·ÃµÈ Áõ»óÀ» ¿ÏÈ­ÇÏ´Â µ¥ »ç¿ëµÇ´Â Ä¡·á¹ýÀÔ´Ï´Ù. HRT´Â ¿¡½ºÆ®·Î°Õ, Ȳü È£¸£¸ó, ¶§·Î´Â Å×½ºÅ佺Å׷аú °°Àº È£¸£¸óÀ» Åõ¿©ÇÏ¿© È£¸£¸ó ¼öÄ¡¸¦ ȸº¹½Ã۰í, È«Á¶, ¶¡, ±âºÐ ÀúÇÏ, Áú °ÇÁ¶ µîÀÇ Áõ»óÀ» ¿ÏÈ­½Ãŵ´Ï´Ù. HRT´Â °æ±¸ Á¤Á¦, °æÇÇ ÆÐÄ¡, °Ö, Å©¸², ÁÖ»çÁ¦ µî ´Ù¾çÇÑ ÇüÅ·ΠÅõ¿©µË´Ï´Ù. ÀÌ Ä¡·á¹ýÀº Æó°æ Áõ»óÀ» °ü¸®ÇÏ´Â µ¥ µµ¿òÀÌ µÉ»Ó¸¸ ¾Æ´Ï¶ó °ñ´Ù°øÁõÀ» ¿¹¹æÇÏ°í »îÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ±×·¯³ª HRT¸¦ ¹Þ´ÂÁö ¿©ºÎ´Â Ç÷Àü, ³úÁ¹Áß, ƯÁ¤ ¾ÏÀÇ °¡´É¼ºÀÌ ³ô¾ÆÁö´Â µîÀÇ ÀáÀçÀû À§ÇèÀÌ Àֱ⠶§¹®¿¡ ÀÇ·á Á¦°ø¾÷ü¿¡ ÀÇÇØ ½ÅÁßÇÏ°Ô Æò°¡µÇ¾î¾ß Çϸç Ä¡·á¿¡ °³º°È­µÈ Á¢±Ù¹ýÀÌ ÇÊ¿äÇÕ´Ï´Ù.

ÇöÀç ÀÇÇÐ ¿¬±¸ÀÇ Áøº¸¿Í ȯÀÚ ¼±È£ÀÇ º¯È­¸¦ ¹Ý¿µÇÏ¿© ÀϺΠµ¿ÇâÀº HRTÀÇ »óȲÀ» Çü¼ºÇϰí ÀÖ½À´Ï´Ù. ÁÖ¸ñÇÒ ¸¸ÇÑ µ¿Çâ Áß Çϳª´Â ¹ÙÀÌ¿À ¾ÆÀ̵§Æ¼Äà ȣ¸£¸óÀÇ °³¹ßÀÔ´Ï´Ù. ¹ÙÀÌ¿À ¾ÆÀ̵§Æ¼Äà ȣ¸£¸óÀº ÀÎü¿¡¼­ ÀÚ¿¬ÀûÀ¸·Î »ý¼ºµÇ´Â È£¸£¸ó°ú È­ÇÐÀûÀ¸·Î µ¿ÀÏÇÕ´Ï´Ù. ÀÌ ¹ÙÀÌ¿À ¾ÆÀ̵§Æ¼Äà ȣ¸£¸óÀº ±âÁ¸ÀÇ ÇÕ¼º È£¸£¸óÀ» ´ëüÇϴº¸´Ù ÀÚ¿¬½º·´°í ¾ÈÀüÇÑ ¿É¼ÇÀ» Á¦°øÇÏ´Â °ÍÀ¸·Î »ý°¢µÇ¸ç ȯÀÚ¿Í °Ç°­ °ü¸® Á¦°ø¾÷ü ¸ðµÎ¿¡°Ô °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡, °³ÀÎÈ­µÈ ÀÇ·á°¡ Áß¿äÇØÁö°í ÀÖÀ¸¸ç, HRT Ä¡·á´Â À¯ÀüÀû, È£¸£¸óÀû, ¶óÀÌÇÁ½ºÅ¸ÀÏ ¿äÀο¡ ±âÃÊÇÏ¿© °³º° ȯÀÚ ÇÁ·ÎÆÄÀÏ¿¡ ¸Â°Ô Á¶Á¤µË´Ï´Ù. ÀÌ Á¢±Ù¹ýÀº À§ÇèÀ» ÃÖ¼ÒÈ­Çϸ鼭 Ä¡·á È¿°ú¸¦ ±Ø´ëÈ­Çϰí ȯÀÚ °á°ú¸¦ °³¼±ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. ±â¼úÀÇ Áøº¸·Î HRTÀÇ Åõ¿©¹æ¹ýµµ °­È­µÇ°í ÀÖÀ¸¸ç, È£¸£¸ó ÀÓÇöõÆ®³ª °íµµÀÇ °æÇÇÈí¼ö ½Ã½ºÅÛ µîÀÇ Çõ½ÅÀû ±â¼ú¿¡ ÀÇÇØ È£¸£¸ó ³óµµ°¡ º¸´Ù ¾ÈÁ¤µÇ°í ȯÀÚÀÇ ÆíÀǼºµµ Çâ»óÇϰí ÀÖ½À´Ï´Ù.

È£¸£¸ó ´ëü¿ä¹ý(HRT) ½ÃÀåÀÇ ¼ºÀåÀº ¿©·¯ ¿äÀο¡ ÀÇÇØ ¹ß»ýÇÕ´Ï´Ù. ÀǾàǰ Á¦Çü ¹× Àü´Þ ½Ã½ºÅÛÀÇ ±â¼úÀû Áøº¸´Â HRTÀÇ È¿´É°ú ¾ÈÀü¼ºÀ» Çâ»ó½Ã۰í È£¸£¸ó ±ÕÇüÀÇ È¥¶õÀ» °ü¸®ÇÏ´Â ¸Å·ÂÀûÀÎ ¼±ÅÃÀÔ´Ï´Ù. ³ëÀÎ ¿©¼º Àα¸¿¡¼­ Æó°æ Áõ»óÀÇ À¯º´·üÀÌ Áõ°¡Çϸé HRT Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »îÀÇ Áú Çâ»ó°ú °ñ´Ù°øÁõ ¿¹¹æ¿¡¼­ HRTÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ´õ ¸¹Àº ¿©¼ºµéÀÌ Ä¡·á¸¦ ¿ä±¸Çϵµ·Ï Ã˱¸Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °³ÀÎÈ­µÈ ÀÇ·á µ¿ÇâÀº °³º° ȯÀÚÀÇ Æ¯Á¤ ¿ä±¸¿¡ ºÎÇÕÇÏ´Â ¸ÂÃãÇü HRT ¿ä¹ýÀÇ °³¹ßÀ» ÃËÁøÇÕ´Ï´Ù. ¹ÙÀÌ¿À ¾ÆÀ̵§Æ¼Äà ȣ¸£¸óÀ» »ç¿ëÇÒ ¼ö ÀÖÀ¸¸ç ÀÌ·¯ÇÑ ÀÚ¿¬ ´ëüǰ¿¡ ´ëÇÑ ¼±È£µµ°¡ Áõ°¡ÇÏ´Â °ÍÀº ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÕ´Ï´Ù. ¶ÇÇÑ ¿©¼ºÀÇ °Ç°­ ÁõÁøÀ» ¸ñÀûÀ¸·Î ÇÑ Á¤ºÎÀÇ Áö¿ø Á¤Ã¥°ú ÀÌ´Ï¼ÅÆ¼ºê°¡ HRT ä¿ëÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀÎÀÌ °áÇյǾî HRT ½ÃÀåÀÇ °ßÁ¶ÇÑ ¼ºÀåÀÌ ÃËÁøµÇ°í Áõ°¡Çϴ ȯÀÚ Áý´ÜÀÇ ¿ä±¸¿¡ ´ëÀÀÇϰí È£¸£¸ó °Ç°­ °ü¸® ºÐ¾ß¸¦ ¹ßÀü½Ã۰í ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÃÑ 47°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Hormone Replacement Therapy (HRT) Market to Reach US$44.6 Billion by 2030

The global market for Hormone Replacement Therapy (HRT) estimated at US$29.3 Billion in the year 2023, is expected to reach US$44.6 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Estrogen Hormone Replacement Therapy, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$24.2 Billion by the end of the analysis period. Growth in the Human Growth Hormone Replacement Therapy segment is estimated at 7.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.8 Billion While China is Forecast to Grow at 5.8% CAGR

The Hormone Replacement Therapy (HRT) market in the U.S. is estimated at US$7.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$7.0 Billion by the year 2030 trailing a CAGR of 5.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.6% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Hormone Replacement Therapy (HRT) - Key Trends and Drivers

Hormone Replacement Therapy (HRT) is a medical treatment used to alleviate symptoms associated with hormonal imbalances or deficiencies, particularly during menopause in women. HRT involves the administration of hormones such as estrogen, progesterone, and sometimes testosterone to restore hormonal levels and alleviate symptoms like hot flashes, night sweats, mood swings, and vaginal dryness. HRT can be delivered through various forms including oral tablets, transdermal patches, gels, creams, and injectable formulations. The therapy not only helps in managing menopausal symptoms but also provides benefits in preventing osteoporosis and improving quality of life. However, the decision to undergo HRT must be carefully evaluated by healthcare providers due to potential risks, such as increased chances of blood clots, stroke, and certain types of cancer, necessitating a personalized approach to treatment.

Several trends are currently shaping the HRT landscape, reflecting advancements in medical research and changing patient preferences. One notable trend is the development of bioidentical hormones, which are chemically identical to the hormones naturally produced by the human body. These bioidentical hormones are perceived to offer a more natural and potentially safer alternative to traditional synthetic hormones, attracting increasing interest from both patients and healthcare providers. Additionally, there is a growing emphasis on personalized medicine, with HRT treatments being tailored to individual patient profiles based on genetic, hormonal, and lifestyle factors. This approach aims to maximize the therapeutic benefits while minimizing risks, thereby improving patient outcomes. Technological advancements are also enhancing the delivery methods of HRT, with innovations such as hormone implants and advanced transdermal systems providing more consistent hormone levels and greater convenience for patients.

The growth in the Hormone Replacement Therapy (HRT) market is driven by several factors. Technological advancements in pharmaceutical formulations and delivery systems are enhancing the efficacy and safety of HRT, making it a more attractive option for managing hormonal imbalances. The increasing prevalence of menopausal symptoms among the aging female population is expanding the demand for HRT treatments. Moreover, the rising awareness about the benefits of HRT in improving quality of life and preventing osteoporosis is encouraging more women to seek treatment. Additionally, the trend towards personalized medicine is driving the development of customized HRT regimens that cater to the specific needs of individual patients. The availability of bioidentical hormones and the growing preference for these natural alternatives are also contributing to market growth. Furthermore, supportive government policies and initiatives aimed at improving women's health are facilitating the adoption of HRT. Collectively, these factors are fostering robust growth in the HRT market, addressing the needs of a growing patient population and advancing the field of hormonal health management.

Select Competitors (Total 47 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â